Dr. Gordon Mills from MD Anderson Cancer Center Gives Examples of Unexpected Therapy Responses
Gordon B. Mills, MD, PhD
Advertisement
Articles by Gordon B. Mills, MD, PhD
Dr. Gordon B. Mills from the University of Texas MD Anderson Cancer Center Discusses the Field of Targeted Therapeutics
Dr. Gordon B. Mills from MD Anderson Cancer Center Discusses the Development of Combination Therapies
Dr. Gordon Mills from MD Anderson Cancer Center Explains the Vulnerability of Cancer Cells
Dr. Gordon B. Mills from MD Anderson Cancer Center Discusses Shifts Towards Personalized Medicine
Advertisement
Latest Updated Articles
Dr. Mills on the Shifts Towards Personalized MedicinePublished: September 29th 2011 | Updated:
Dr. Mills Explains the Vulnerability of Cancer CellsPublished: October 3rd 2011 | Updated:
Dr. Mills on the Development of Combination TherapiesPublished: October 7th 2011 | Updated:
Dr. Mills Discusses the Field of Targeted TherapeuticsPublished: October 18th 2011 | Updated:
Dr. Mills Gives Examples of Unexpected Drug ResponsesPublished: October 28th 2011 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
4
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
5